Digestive Diseases and Sciences

, Volume 53, Issue 10, pp 2697–2701 | Cite as

Immunoreactivity of Antibodies Against Transglutaminase-Deamidated Gliadins in Adult Celiac Disease

  • Maria Letizia Falini
  • Luca Elli
  • Rosita Caramanico
  • Maria Teresa Bardella
  • Claudia Terrani
  • Leda Roncoroni
  • Luisa Doneda
  • Fabio Forlani
Original Paper

Abstract

Background The significance of the presence of anti-gliadin antibodies in patients affected by celiac disease is still unclear. It is hypothesized that gliadin deamidation, catalysed by transglutaminase, plays a role in favoring the antigen presentation. Aim To determine the immunoreactivity of anti-gliadin antibodies from untreated celiac patients to transglutaminase deamidated gliadins. Materials and methods Gliadins from wheat flour underwent enzymatic digestion and were deamidated or cysteamine-transamidated by transglutaminase. Immunoreactivity of anti-gliadin antibodies from untreated adult celiac patients sera was evaluated by means of a competitive enzyme-linked immunosorbent assay (ELISA) method. Results Gliadin deamidation increased antibodies immunoreactivity from 25% to 50% while cysteamine incorporation into the gliadin peptides resulted in an immunoreactivity decrease. Conclusions Increased immunoreactivity of transglutaminase deamidated gliadins tested with anti-gliadin antibodies from untreated adult celiac patients supports the hypothesis of a pivotal role of gliadin deamidation in the pathomechanism of celiac disease.

Keywords

Celiac disease Gliadin Anti-gliadin antibodies Transglutaminase 

Notes

Acknowledgements

The authors particularly thank the Lombardy Section of the Italian Association for Celiac Disease for its support.

References

  1. 1.
    Schuppan D (2000) Current concepts of celiac disease pathogenesis. Gastroenterology 119:234–242PubMedCrossRefGoogle Scholar
  2. 2.
    Howdle PD (2006) Gliadin, glutenin or both? The search for the Holy Grail in coeliac disease. Eur J Gastroenterol Hepatol 18:703–706PubMedCrossRefGoogle Scholar
  3. 3.
    van Heel DA, West J (2006) Recent advances in coeliac disease. Gut 55:1037–1046PubMedCrossRefGoogle Scholar
  4. 4.
    Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature’s biological glues. Biochem J 368:377–396PubMedCrossRefGoogle Scholar
  5. 5.
    Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C (2002) Structural basis for gluten intolerance in celiac sprue. Science 297:2275–2279PubMedCrossRefGoogle Scholar
  6. 6.
    Aleanzi M, Demonte AM, Esper C, Garcilazo S, Waggener M (2001) Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 47:2023–2028PubMedGoogle Scholar
  7. 7.
    Osman AA, Gunnel T, Dietl A, Uhlig HH, Amin M, Fleckenstein B, Richter T, Mothes T (2000) B cell epitopes of gliadin. Clin Exp Immunol 121:248–254PubMedCrossRefGoogle Scholar
  8. 8.
    Rostom A, Murray JA, Kagnoff MF (2006) American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 131:1981–2002PubMedCrossRefGoogle Scholar
  9. 9.
    Capelli L, Forlani F, Perini F, Guerrieri N, Cerletti P, Righetti PG (1998) Wheat cultivar discrimination by capillary electrophoresis of gliadins in isoelectric buffers. Electrophoresis 19:311–318PubMedCrossRefGoogle Scholar
  10. 10.
    Dolfini E, Elli L, Dasdia T, Bufardeci B, Colleoni MP, Costa B, Floriani I, Falini ML, Guerrieri N, Forlani F, Bardella MT (2002) In vitro cytotoxic effect of bread wheat gliadin on the LoVo human adenocarcinoma cell line. Toxicol In Vitro 16:331–337PubMedCrossRefGoogle Scholar
  11. 11.
    Mamone G, Ferranti P, Melck D, Tafuro F, Longobardo L, Chianese L, Addeo F (2004) Susceptibility to transglutaminase of gliadin peptides predicted by a mass spectrometry-based assay. FEBS Lett 562:177–182PubMedCrossRefGoogle Scholar
  12. 12.
    Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77PubMedCrossRefGoogle Scholar
  13. 13.
    Berti C, Roncoroni L, Falini ML, Caramanico R, Dolfini E, Bardella MT, Elli L, Terrani C, Forlani F (2007) Celiac-related properties of chemically and enzymatically modified gluten proteins. J Agric Food Chem 55:2482–2488PubMedCrossRefGoogle Scholar
  14. 14.
    Wieser H (1996) Relation between gliadin structure and coeliac toxicity. Acta Paediatr 412(Suppl):3–9CrossRefGoogle Scholar
  15. 15.
    Stepniak D, Koning F (2006) Celiac disease–sandwiched between innate and adaptive immunity. Hum Immunol 67:460–468PubMedCrossRefGoogle Scholar
  16. 16.
    Spaenij-Dekking L, Kooy-Winkelaar Y, van Veelen P, Drijfhout JW, H Jonker van Soest L, Smulders MJ, Bosch D, Gilissen LJ, Koning F (2005) Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 129:797–806PubMedCrossRefGoogle Scholar
  17. 17.
    Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, Picard J, Osman M, Quaratino S, Londei M (2003) Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362:30–37PubMedCrossRefGoogle Scholar
  18. 18.
    Ewe K, Schwartz S, Petersen S, Press AG (1999) Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease. Dig Dis Sci 44:1434–1439PubMedCrossRefGoogle Scholar
  19. 19.
    Malandain H (2005) Transglutaminases: a meeting point for wheat allergy, celiac disease, and food safety. Allerg Immunol (Paris) 37:397–403Google Scholar
  20. 20.
    Yokoyama K, Nio N, Kikuchi Y (2004) Properties and applications of microbial transglutaminase. Appl Microbiol Biotechnol 64:447–454PubMedCrossRefGoogle Scholar
  21. 21.
    Prince HE (2006) Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol 13:150–151PubMedCrossRefGoogle Scholar
  22. 22.
    Hill ID (2005) What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology 128:S25–S32PubMedCrossRefGoogle Scholar
  23. 23.
    Volta U, Granito A, Fiorini E, Parisi C, Piscaglia M, Pappas G, Muratori P, Bianchi FB (2007) Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci. doi:  10.1007/s10620-007-0058-0
  24. 24.
    Kaukinen K, Collin P, Laurila K, Kaartinen T, Partanen J, Maki M (2007) Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol 42:1428–1433 PubMedCrossRefGoogle Scholar
  25. 25.
    Ankelo M, Kleimola V, Simell S, Simell O, Knip M, Jokisalo E, Tarkia M, Westerlund A, He Q, Viander M, Ilonen J, Hinkkanen AE (2007) Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease. Clin Exp Immunol 150:285–293PubMedCrossRefGoogle Scholar
  26. 26.
    Niveloni S, Sugai E, Cabanne A, Vazquez H, Argonz J, Smecuol E, Moreno ML, Nachman F, Mazure R, Kogan Z, Gomez JC, Maurino E, Bai JC (2007) Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem 53:2186–2192PubMedCrossRefGoogle Scholar
  27. 27.
    Liu E, Li M, Emery L, Taki I, Barriga K, Tiberti C, Eisenbarth GS, Rewers MJ, Hoffenberg EJ (2007) Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr 45:293–300PubMedCrossRefGoogle Scholar
  28. 28.
    Agardh D (2007) Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin Gastroenterol Hepatol 5:1276–1281PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Maria Letizia Falini
    • 1
  • Luca Elli
    • 2
    • 3
  • Rosita Caramanico
    • 1
  • Maria Teresa Bardella
    • 2
  • Claudia Terrani
    • 2
  • Leda Roncoroni
    • 2
    • 3
  • Luisa Doneda
    • 4
  • Fabio Forlani
    • 1
  1. 1.Department of Agrifood Molecular ScienceUniversity of MilanMilanItaly
  2. 2.Center for the Prevention and Diagnosis of Celiac DiseaseFondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina ElenaMilanoItaly
  3. 3.Department of Medical SciencesUniversity of MilanMilanItaly
  4. 4.Department of Biology and Genetic for Medical SciencesUniversity of MilanMilanItaly

Personalised recommendations